Acadian Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-928,205
| Closed | -$2.11M | – | 2401 |
|
|
2024
Q2 | $2.11M | Buy |
928,205
+494,496
| +114% | +$1.13M | 0.01% | 743 |
|
|
2024
Q1 | $1.87M | Buy |
433,709
+375,354
| +643% | +$1.62M | 0.01% | 674 |
|
|
2023
Q4 | $177K | Sell |
58,355
-73,230
| -56% | -$222K | ﹤0.01% | 1256 |
|
|
2023
Q3 | $189K | Buy |
+131,585
| New | +$189K | ﹤0.01% | 1200 |
|
|
2023
Q1 | – | Sell |
-30,475
| Closed | -$165K | – | 2016 |
|
|
2022
Q4 | $165K | Buy |
+30,475
| New | +$165K | ﹤0.01% | 1332 |
|
|
2020
Q2 | – | Sell |
-5,876
| Closed | -$65K | – | 2366 |
|
|
2020
Q1 | $65K | Buy |
+5,876
| New | +$65K | ﹤0.01% | 1452 |
|
|
2019
Q2 | – | Sell |
-18,371
| Closed | -$305K | – | 2082 |
|
|
2019
Q1 | $305K | Buy |
+18,371
| New | +$305K | ﹤0.01% | 1246 |
|